Salidroside targeted cytosolic phospholipase A2 and regulated arachidonic acid metabolomics to attenuate atherosclerosis progression
Lipid metabolism disturbances are linked to the development of atherosclerosis (AS), with arachidonic acid (AA) and other downstream metabolites being involved. Cytosolic phospholipase A2 (cPLA2) is a key restriction enzyme in AA metabolism. Salidroside (SAL) reportedly alleviates AS by inhibiting i...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | All Life |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/26895293.2025.2515449 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|